Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insulina bniedem winthrop mgħaġġla huwa wkoll adattat għat-trattament ta ' koma hyperglycaemic u ketoacidosis, kif ukoll għall-kisba minn qabel, intra - u postoperative stabbilizzazzjoni fil-pazjenti bl-diabetes mellitus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drogi użati fid-dijabete - dijabete mellitus fejn huwa meħtieġ it-trattament bl-insulina. insuman rapid huwa wkoll adattat għall-kura ta 'koma ipergliċemika u ketoaċidożi, kif ukoll għall-kisba ta' stabilizzazzjoni minn qabel, intra u wara l-operazzjoni f'pazjenti bid-dijabete mellitus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - deġenerazzjoni makulari mxarrba - oftalmoloġiċi - macugen huwa indikat għat-trattament ta 'deġenerazzjoni makulari neovaskulari (mxarrba) relatata ma' l-età (amd).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

zoetis belgium sa - ceftiofur - antibacterials għal użu sistemiku - pigs; cattle - pigstreatment of bacterial respiratory disease associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis and streptococcus suis. kura tas-settiċemija, poliartrite jew polyserositis assoċjata ma 'infezzjoni ta' streptococcus suis. cattletreatment of acute interdigital necrobacillosis in cattle also known as panaritium or foot rot. trattament ta 'metritis akut post-partum (puerperali) fil-bhejjem, f'każijiet fejn it-trattament b'anti-mikrobi ieħor falla.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

recordati ireland ltd. - lidocaine, prilocaine - disfunzjoni sesswali, fiżjoloġika - anestetiċi - trattament tal-eġakulazzjoni primarja prematura fl-irġiel adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novo nordisk a/s - insulin human - diabetes mellitus - drogi użati fid-dijabete - trattament tad-dijabete mellitus.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

dynavax gmbh - antigen tal-wiċċ ta 'l-epatite b - epatite b - vaċċini - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - infezzjonijiet ta 'virus sintetiku respiratorju - vaċċini - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. ara t-taqsimiet 4. 2 u 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. l-użu ta ' dan il-vaċċin għandha tkun skond ir-rakkomandazzjonijiet uffiċjali.